TG Therapeutics Inc. (TGTX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

TG Therapeutics Inc.

NASDAQ: TGTX · Real-Time Price · USD
36.70
0.04 (0.11%)
At close: Oct 03, 2025, 3:59 PM
36.66
-0.12%
After-hours: Oct 03, 2025, 07:33 PM EDT

TG Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
60.46M 39.15M 23.38M -14.36M 95.69M 41.2M 12.67M -25.91M -175.65M -168.55M -198.34M -238.68M -288.5M -326.49M -348.1M -342.98M -344.51M -318.89M
Depreciation & Amortization
241K 254K 280K 309K 371K 384K 423K 458K 461K 507K 515K 522K 522K 511K 494K 467K 432K 402K
Stock-Based Compensation
55.05M 48.17M 42.54M 39.98M 37.39M 40.45M 37.93M 39.6M 37.4M 23.89M 19.18M 22.49M 29.5M 46.78M 61.27M 80.44M 94.77M 85.84M
Other Working Capital
-4.68M 1.39M 12.81M 3.92M 19.47M 17.87M 10.7M 21.05M 34.36M 25.17M 24.4M -1.36M -17.36M -6.76M -3.4M 476K -7.22M -8.67M
Other Non-Cash Items
2.97M 3.17M 2.58M 26.88M 8.36M 9.93M 11.5M -11.63M 4.52M 3.83M 4.11M 3.77M 2.85M 2.73M 2.4M 3.46M 2.12M 2.44M
Deferred Income Tax
n/a n/a n/a -24.28M -9.09M -9.28M -9.28M 15M -186K n/a n/a 96K 235K 390K 517K 466K 321K 141K
Change in Working Capital
-177.85M -151.77M -109.3M -56.61M -64.89M -62.4M -84.66M -59.6M -26.82M -27.06M -1.65M -27.41M -16.52M -6.89M -12.22M -2.6M -3.22M -3.67M
Operating Cash Flow
-59.13M -61.02M -40.52M -28.09M 67.82M 20.28M -31.41M -42.07M -160.27M -167.38M -176.17M -239.21M -271.92M -282.97M -295.63M -260.75M -250.08M -233.75M
Capital Expenditures
-112K -70K -45K -24K n/a n/a n/a -3K -7K -7K -14K -91K -166K -341K -401K -476K -486K -356K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a 2.99M 2.99M 46.66M 46.66M 43.67M 43.67M 514K 514K 514K 514K
Purchase of Investments
-306.11M -322.54M -311.89M -322.43M -277.1M -207.37M -146.88M -82.44M -57.63M -72.55M -107.27M -115.51M -95.84M -94.97M -55.53M -103.22M -91.42M -77.37M
Sales Maturities Of Investments
295.75M 317.9M 310.9M 260.88M 194.63M 153.63M 96.23M 92.82M 95.25M 90.05M 87.28M 82.61M 65.38M 51.83M 55.6M 48M 51.75M 51.25M
Other Investing Acitivies
n/a n/a n/a n/a -30.23M 272K -5.9M -5.9M 21.35M 1.23M -36.28M -32.91M -30.48M -43.16M 2K -55.29M -39.73M -26.18M
Investing Cash Flow
-10.47M -4.71M -1.04M -61.58M -82.47M -53.74M -50.65M 10.37M 37.61M 17.49M -20.01M -32.99M -30.64M -43.49M -332K -55.7M -40.15M -26.47M
Debt Repayment
n/a n/a n/a 137.26M n/a n/a 25M 25M 25M 25M -975K 53.62M 46.23M 39.02M 40M -14.59M -7.2M n/a
Common Stock Repurchased
-21.76M -14.88M -8.76M -2.15M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
137.59M 137.16M 137.14M -659K 420K 47.47M 47.7M 47.75M 47.61M 697K 584K -277K -523K -620K -800K 24K 34K 11K
Financial Cash Flow
115.84M 122.42M 128.53M 134.6M 565K 47.48M 72.7M 72.75M 72.61M 25.7M -391K 55.56M 47.92M 40.62M 41.42M 388.81M 431.44M 679.69M
Net Cash Flow
46.24M 56.67M 86.97M 44.92M -14.1M 14.01M -9.36M 41.05M -50.05M -124.2M -196.57M -216.65M -254.63M -285.83M -254.55M 72.36M 141.2M 419.47M
Free Cash Flow
-59.24M -61.09M -40.56M -28.11M 67.82M 20.28M -31.41M -42.08M -160.28M -167.39M -176.18M -239.3M -272.08M -283.31M -296.04M -261.23M -250.57M -234.1M